Wendy Chung is director of clinical research at SFARI and the principal investigator of SPARK (Simons Foundation Powering Autism Research) and Simons Searchlight. She manages the research program in individuals with autism, evaluating opportunities to develop new treatments for autism including medications such as arbaclofen, and developing novel outcome measures to evaluate the efficacy of these treatments. She is involved in identifying novel genes for autism and characterizing the clinical features associated with these novel genes. She is leading the effort to build a community of individuals with autism and their families, working with them to better understand the causes of autism.